Keratoderma palmaris et plantaris - Symptoms, Causes, Treatment & Prevention

```html Keratoderma Palmaris et Plantaris – Complete Medical Guide

Keratoderma Palmaris et Plantaris – A Comprehensive Medical Guide

Overview

Keratoderma palmaris et plantaris (KPPP) is a group of hereditary or acquired skin disorders that cause abnormal thickening (hyperkeratosis) of the skin on the palms of the hands and the soles of the feet. The condition may appear as diffuse, patchy, or focal thickening and can be associated with pain, fissuring, or reduced grip. While many cases are inherited in an autosomal‑dominant pattern, KPPP can also develop secondary to systemic diseases, infections, or medication exposure.

Who it affects: Most cases present in childhood or early adulthood, but late‑onset forms have been reported. Both sexes are affected equally, although certain genetic subtypes (e.g., Vohwinkel syndrome) show a slight male predominance.

Prevalence: Exact global prevalence is unknown because KPPP is rare and often under‑diagnosed. Epidemiologic surveys estimate a prevalence of roughly 1‑2 per 100,000 individuals for the more common autosomal‑dominant forms, while rare syndromic variants occur in <0.1 per 100,000.[1] WHO, 2022

Symptoms

Symptoms vary by subtype and severity. Below is a comprehensive list:

Skin‑related signs

  • Diffuse hyperkeratosis: Uniform thickening of the entire palm and/or sole.
  • Focal plaques: Well‑defined, raised, waxy lesions that may have a "rain‑drop" or "pebble‑like" appearance.
  • Vesicles or pustules: Occasionally appear before thickening, especially in epidermolytic variants.
  • Fissuring: Deep cracks in the skin that can bleed or become infected.
  • Palmar/plantar hyperhidrosis: Excessive sweating that worsens maceration.
  • Palmar creases: May be deepened or obscured by thick skin.

Pain & functional impact

  • Burning or tenderness when walking or using hands.
  • Reduced grip strength and dexterity.
  • Difficulty wearing shoes, leading to callus formation on toes.

Associated systemic features (in syndromic forms)

  • Hearing loss (e.g., in Vohwinkel syndrome).
  • Nail dystrophy or onycholysis.
  • Dental anomalies, short stature, or cardiac defects depending on the genetic mutation.

Causes and Risk Factors

Genetic causes (hereditary KPPP)

More than 15 genes have been implicated. The most common include:

  • KRT9 – Keratin 9 mutations cause classic epidermolytic palmoplantar keratoderma.
  • GJB2 – Connexin 26 mutations lead to Vohwinkel syndrome.
  • SLURP1 – Causes Mal de Meleda, an autosomal‑recessive diffuse keratoderma.
  • AQP5, AQP9 – Aquaporin channel mutations linked to aquagenic keratoderma.

Inheritance patterns are usually autosomal dominant, but autosomal recessive and X‑linked forms exist.[2] NIH Genetics, 2023

Acquired causes

  • Systemic diseases: Psoriasis, eczema, ichthyosis, lupus, or endocrine disorders (thyroid disease, diabetes).
  • Infections: Chronic fungal (tinea pedis/manuum) or bacterial infections.
  • Medications: Long‑term retinoids, penicillamine, or arsenic exposure.
  • Physical factors: Repeated mechanical pressure (e.g., manual labor, sports), excessive heat, or chronic moisture.

Risk factors

  • Family history of palmoplantar keratoderma.
  • Occupations with heavy hand/foot use (construction, mechanics, athletes).
  • Underlying skin conditions (psoriasis, atopic dermatitis).
  • Uncontrolled diabetes or peripheral vascular disease.

Diagnosis

Diagnosing KPPP involves a combination of clinical assessment, family history, and targeted investigations.

Clinical evaluation

  1. History: Onset age, progression, family members with similar findings, exposure to irritants, and systemic symptoms.
  2. Physical exam: Detailed inspection of palms and soles, documentation of distribution, thickness, fissuring, and any extra‑cutaneous signs.

Dermatologic tools

  • Dermoscopy: Reveals characteristic patterns (e.g., “cobblestone” or “snowflake” hyperkeratosis).
  • Skin biopsy: Histology shows hyperkeratosis, acanthosis, and, in epidermolytic variants, vacuolated keratinocytes with eosinophilic granules.

Genetic testing

When a hereditary form is suspected, next‑generation sequencing panels targeting KRT9, GJB2, SLURP1, and related genes are recommended. In many countries, testing is covered when a clear family pattern exists.[3] Cleveland Clinic, 2024

Laboratory & imaging (for acquired forms)

  • Baseline blood work (CBC, fasting glucose, thyroid panel) to rule out systemic disease.
  • Fungal culture or KOH prep if a tinea infection is suspected.
  • Radiographs only if there is suspicion of underlying bony involvement (rare).

Treatment Options

Therapy is individualized based on severity, underlying cause, and patient preferences.

Topical agents

  • Urea 10‑40% creams: Softens hyperkeratotic plaques; applied twice daily.
  • Salicylic acid 2‑6%: Keratolytic; useful for focal plaques.
  • Retinoids (tazarotene 0.05%): Reduces keratinocyte proliferation; may cause irritation.
  • Corticosteroid ointments: Short‑term for inflammatory flares or fissures.
  • Systemic medications

    • Oral retinoids (acitretin, isotretinoin): First‑line for widespread, refractory disease. Typical dose: acitretin 0.5‑1 mg/kg/day. Monitor liver function, lipids, and pregnancy status.
    • Low‑dose methotrexate: Considered when inflammatory components dominate (e.g., psoriatic KPPP).
    • Biologic agents: Limited data, but case reports suggest efficacy of IL‑17 or IL‑23 inhibitors in keratoderma associated with psoriasis.

    Procedural interventions

    • Mechanical debridement: Salabrasion or gentle filing to remove excess keratin under medical supervision.
    • Laser therapy: CO₂ or Er:YAG lasers can precisely ablate thickened skin with minimal downtime.
    • Photodynamic therapy (PDT): Emerging option for focal lesions.

    Adjunctive measures

    • Moisturizing regimen: Thick, fragrance‑free emollients (e.g., petrolatum, ceramide‑rich creams) immediately after bathing.
    • Foot/hand orthoses: Cushioned insoles, padded gloves, or custom shoe inserts to reduce pressure.
    • Hyperhidrosis control: Aluminium chloride antiperspirants, iontophoresis, or botulinum toxin injections for excessive sweating.

    Lifestyle & self‑care

    Adopt a regimen of gentle exfoliation (e.g., pumice stone after soaking) 2‑3 times/week, keep nails trimmed, and avoid walking barefoot on rough surfaces.

    Living with Keratoderma Palmaris et Plantaris

    Daily skin‑care routine

    1. Morning: Warm water soak (5‑10 min), apply urea cream, and gently pat dry.
    2. Mid‑day: Re‑apply a thin layer of emollient if hands/feet become dry.
    3. Evening: Repeat soak, followed by a heavier moisturizer or night‑time occlusive dressing (e.g., gauze soaked in petroleum jelly).

    Footwear tips

    • Choose breathable, cushioned shoes with a wide toe box.
    • Rotate shoes every 2‑3 days to allow drying.
    • Use moisture‑wicking socks (cotton or bamboo) and change them if they become damp.

    Work‑place adaptations

    • Wear protective gloves with a soft lining for repetitive manual tasks.
    • Take short, frequent breaks to relieve pressure.
    • Use anti‑fatigue mats if standing for long periods.

    Psychosocial coping

    Visible skin changes can affect confidence. Consider counseling, support groups, or patient‑led forums (e.g., RareSkin.org). Many patients find relief in documenting improvement with photos, which can also help clinicians adjust therapy.

    Prevention

    While hereditary forms cannot be prevented, several strategies lessen severity and reduce the risk of secondary complications:

    • Maintain optimal skin hydration—apply emollients immediately after baths.
    • Avoid chronic exposure to irritants (strong detergents, solvents). Use gloves when handling chemicals.
    • Control hyperhidrosis early; excess moisture softens the stratum corneum and promotes maceration.
    • Treat any underlying fungal or bacterial infection promptly.
    • For families with known mutations, genetic counseling before pregnancy can provide reproductive options (pre‑implantation genetic testing, donor gametes).

    Complications

    If left untreated or poorly managed, KPPP may lead to:

    • Infections: Bacterial cellulitis, Staphylococcus aureus or Streptococcus infections of fissures.
    • Secondary fungal overgrowth: Tinea pedis/manuum, especially in moist environments.
    • Mobility limitations: Painful walking or grip loss can affect daily activities and employment.
    • Ulceration: Deep fissures may progress to chronic ulcers, particularly in diabetics.
    • Psychological impact: Depression or anxiety due to cosmetic concerns.

    When to Seek Emergency Care

    Call 911 or go to the nearest emergency department if you notice any of the following:
    • Rapid spreading redness, swelling, or warmth around the palms/soles accompanied by fever (>38 °C / 100.4 °F).
    • Severe, uncontrolled pain that does not improve with over‑the‑counter analgesics.
    • Signs of a deep infection: pus, foul odor, or an ulcer that is rapidly enlarging.
    • Sudden loss of sensation or motor function in the hands or feet.
    • Any indication of systemic toxicity (e.g., confusion, rapid heartbeat) after starting systemic retinoids or other medications.

    Early treatment of acute infections or complications can prevent permanent damage.

    References

    1. World Health Organization. “Rare Skin Disorders: Global Estimates.” WHO Press, 2022.
    2. National Institutes of Health – Genetics Home Reference. “Keratoderma Palmaris et Plantaris.” Updated 2023.
    3. Cleveland Clinic. “Genetic Testing for Palmoplantar Keratoderma.” Patient Education, 2024.
    4. Mayo Clinic. “Retinoids: Uses, Side Effects, and Precautions.” 2023.
    5. American Academy of Dermatology. “Management of Palmoplantar Keratoderma.” Clinical Practice Guidelines, 2023.
    ```

    ⚠ Medical Disclaimer

    Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

    If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.